- |||||||||| 5-fluorouracil / Generic mfg., oxaliplatin / Generic mfg., leucovorin calcium / Generic mfg.
New P2 trial: Second Look Laparoscopy in Colorectal Cancer (clinicaltrials.gov) - Jun 24, 2012 P2, N=140, Recruiting,
- |||||||||| tivantinib (ARQ 197) / Daiichi Sankyo, Kyowa Kirin, Merck (MSD)
New P1/2 trial, Combination therapy, Metastases: Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach (clinicaltrials.gov) - Jun 3, 2012 P1/2, N=50, Active, not recruiting,
- |||||||||| Stivarga (regorafenib) / Bayer
Trial completion, Combination therapy, Metastases: Study to Determine Safety, Pharmacokinetics, Pharmacodynamics of BAY73-4506 in Combination With mFOLFOX6 or FOLFIRI (clinicaltrials.gov) - May 14, 2012 P1, N=45, Completed, Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| Zolinza (vorinostat) / Merck (MSD)
Trial completion, Combination therapy, Metastases: Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors (clinicaltrials.gov) - Apr 24, 2012 P1, N=54, Completed, Recruiting --> Active, not recruiting Active, not recruiting --> Completed
|